GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » Profitability Rank

Medicofarma Biotech (WAR:MDB) Profitability Rank : 2 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech Profitability Rank?

Medicofarma Biotech has the Profitability Rank of 2. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Medicofarma Biotech's Operating Margin % for the quarter that ended in Mar. 2024 was -2.87%. As of today, Medicofarma Biotech's Piotroski F-Score is 5.


Competitive Comparison of Medicofarma Biotech's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicofarma Biotech's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's Profitability Rank falls into.



Medicofarma Biotech Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Medicofarma Biotech has the Profitability Rank of 2. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Medicofarma Biotech's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=-0.025 / 0.872
=-2.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Medicofarma Biotech has an F-score of 5 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Medicofarma Biotech Profitability Rank Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicofarma Biotech (WAR:MDB) Business Description

Traded in Other Exchanges
N/A
Address
ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.